HSA approves molnupiravir
Singapore OKs molnupiravir for COVID-19 treatment
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Most Read
1. IHH Healthcare and UOB ink $300m sustainability-linked loan 2. APAC’s price controls, tendering processes pose risks to pharma firms 3. Advancing kidney care in Singapore to extend lives, expand possibilities for patients 4. US foreign aid cuts pressure health systems in emerging markets 5. US tariffs to impact 78% of 510k-approved hospital suppliesResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
The hospital has significantly improved the survivability, health literacy, morale and well-being of military personnel.
